ARTICLE | Company News
GZMO, BruCells in licensing deal
June 4, 2001 7:00 AM UTC
BruCells (Brussels, Belgium) granted Genzyme Molecular Oncology (GZMO) an exclusive license to its technology for the fusion of dendritic and tumor cells. GZMO also will sponsor a two-year research pr...